Abiopharma

🔍 Dickerman Jeffrey F (Executive)

Company: EXPEDITORS INTERNATIONAL OF WASHINGTON INC (EXPD)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 766 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: M | equity_swap_involved: false | shares_owned_after: 9,585.55 | transaction_form_type: 4
• Acquired 28 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: M | equity_swap_involved: false | shares_owned_after: 9,613.67 | transaction_form_type: 4
• Sold 313 shares of Common Stock at $147.89 per share (Direct)
  Date: 2026-05-01 | Code: F | equity_swap_involved: false | shares_owned_after: 9,300.67 | transaction_form_type: 4
• Acquired 1 shares of Restricted Stock Units ("RSUs") (Derivative)
  Date: 2026-05-01 | Code: A | equity_swap_involved: false | shares_owned_after: 765.89 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 766 shares of Restricted Stock Units ("RSUs") (Derivative)
  Date: 2026-05-01 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 28 shares of Dividend Equivalent Rights - 2023 RSUs (Derivative)
  Date: 2026-05-01 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F1

Footnotes:

• F1: Each RSU and DER represent a contingent right to receive the economic equivalent of one common shares of the issuer. The RSUs and DERs vested on May 1, 2026.